Hepatitis A vaccine

Indicated for the prevention of disease caused by hepatitis A virus in person is 12 months of age and older.

The primary dose should be given at least two weeks prior to expected exposure to hepatitis A virus.

Essentially all recipients develop neutralizing antibodies.

Less effective in patients with transplant recipients, immunocompromised patients and patients with chronic liver disease.

Approved for children over the age of 2 years.

Effective for postexposure prophylaxis.

Leave a Reply

Your email address will not be published. Required fields are marked *